Author:
MUTLU ALTUNDAG Ergul,BECER Eda,GENCALP Duygu,VATANSEVER Seda
Publisher
Ankara Universitesi Eczacilik Fakultesi Dergisi
Subject
Pharmaceutical Science,Pharmacology
Reference24 articles.
1. 1. Akkuzu, M.Z., Küçüköner, M., Irtegun, S et al. (2019). Meme Kanserinde Brca-1 ve Brca-2’ de Sık Görülen Polimorfizm Mutasyonların Bölgemizde Varlığı. Dicle Med J, 46, 623–631 .
2. 2. Elbachiri, M., Fatima, S., Bouchbika, Z et al. (2017). Breast cancer in men: About 40 cases and literature review. Pan Afr. Med. J, 28, 287.
3. 3. Foley, N.M., Coll, J.M., Lowery, A.J et al. (2018). Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER−/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact? Pathol. Oncol. Res, 24, 881–884.
4. 4. Anderson, W.F, Chatterjee. N., Ershler, W.B, Brawley, O.W. (2002). Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res. Treat, 76, 27–36.
5. 5. Nadji, M., Gomez-Fernandez, C., Ganjei-Azar, P., Morales, A.R. (2005). Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered. Am. J. Clin. Pathol, 123, 21–27.